Arthur D. Little Delivers AV Market Insight in Latest Autonomous Mobility Journal
6.3.2023 15:00:00 EET | Business Wire | Press release
Arthur D. Little (ADL) has published the fourth edition of its Autonomous Mobility Journal, which looks at the latest developments in autonomous vehicles (AVs) and the market for autonomous mobility going forward.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230306005447/en/
Arthur D. Little: Autonomous Mobility Journal, Fourth Edition (Graphic: Business Wire)
As well as highlighting current industry dynamics, the journal also includes:
- A special focus on robotaxis around the world
- An overview of the AV market in Hong Kong
- An interview with Prof. Omaimah Bamasag, Deputy of Transport Enablement at the Transport General Authority of the Kingdom of Saudi Arabia
While the AV market remains in its infancy and, like other industries, has suffered setbacks due to the Covid-19 pandemic and semiconductor shortages, companies are still working hard to advance AV technologies to the point of mainstream acceptance and deployment. The buoyancy of the global electric vehicle (EV) market also provides a technology pathway for autonomous mobility features to be more readily adopted in the coming years.
An interesting aspect of the autonomous mobility landscape is the high number of start-ups in this space that have gone public through special-purpose acquisition companies (SPACs) rather than more conventional IPOs. Many of these companies have shown fragility and lack of resilience in a difficult market context – however, it is hoped that increased focus on EV innovation by major OEMs will create additional traction in the AV market, and boost the prospects of AV start-ups.
ADL believes that the outlook for robotaxis is more positive, with “city robotaxis” which can operate in any mapped area of a city, even in extreme weather conditions, likely by 2027. “Anywhere robotaxis”, which can operate on unmapped or unmade roads, could also be a reality by 2030.
ADL’s analysis of the AV market in Hong Kong reveals how it has positioned itself as a leader in the autonomous mobility ecosystem through the successful coordination of key elements, including strategy, regulations, stakeholder integration, infrastructure and technology. Finally, Prof. OmaimahBamasag outlines Saudi Arabia’s ambitious goals for AV transport, including major autonomy-based initiatives such as the Neom and Red Sea projects in the Kingdom’s economic zone.
Joseph Salem, Partner in ADL’s Travel & Transportation practice, comments: “While the development of autonomous mobility solutions globally remains experiential, industry players are clearly on the lookout for technological and business model innovation to unlock value-creating use cases. In this journal, we provide a realistic overview of recent developments and industry dynamics, including the key considerations and challenges that the AV market currently faces. We hope it provides food for thought and look forward to feedback from our readers.”
The journal is available for download here: https://tinyurl.com/24cr7dxj
For further information, please visit www.adlittle.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230306005447/en/
Contact information
Cate Bonthuys / Sue Glanville
Catalyst Comms
+44 7746 546773
info@catalystcomms.co.uk
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 13:38:00 EEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 12:48:00 EEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
Ant International Launches Industry's First Full-Stack AI-Native Solutions for Payment, Account, FX, Treasury and Growth Operations for Global Businesses18.9.2026 09:53:00 EEST | Press release
In an industry first, Ant International launched a full stack of AI-native solutions for payment, account, FX, treasury and growth operations for global businesses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260917771311/en/ Peng Yang, CEO of Ant International, introduced the company’s payment foundation model at Ant International's 2026 global merchant event The AI-native product suite is built on a 2-layered security architecture, and our 2 proprietary foundation models: a payment foundation model (Antom 3-in-1 Transformer), and a time-series transformer (TST) forecasting model for FX and liquidity (FalconTST). Underpinning the FinAI stack are also 2 major pillars for payment interoperability for the AI era: our Agentic Mobile Protocol (AMP) and a blockchain-based wholesale settlement platform (WhaleRTP). This round of sweeping product upgrade aims to support all businesses with an AI action plan to complete two critic
Takeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems18.9.2026 08:00:00 EEST | Press release
Takeda (TSE:4502/NYSE: TAK) announced that it has awarded a total of USD 22.2 million to four new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to supporting climate-resilient health systems in low- and middle-income countries around the world and aligned with the company’s purpose of better health for people, brighter future for the world. As climate change, extreme weather events and shifting global aid priorities continue to challenge healthcare access, Takeda is advancing its 2026 collaborations with the goal of expanding equitable access, strengthening health system resilience and improving patient outcomes. These efforts focus on locally led solutions that enhance health infrastructure, prepare the healthcare workforce and leverage innovation to sustain essential services for climate-vulnerable communities. “Takeda has made a generational promise to improve health, and for the last 10 years, our Global CSR Program has given our
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
